Vascular endothelial cells line the inner surface of blood vessels, serving as a selective barrier between the blood and tissues/organs. Constantly exposed to both biochemical and biomechanical stimuli, endothelial cells regulate bodily homeostasis in response to events such as inflammation and ischemia-reperfusion (1) . A number of in vivo and in vitro studies have demonstrated that the endothelium responds to blood flow by both transcriptional and post-transcriptional mechanisms (2) (3) (4) (5) . An elaborate and complex structure of arterial trees results in changes in blood flow and generates altered hemodynamic forces. At bends and bifurcations in the aorta, where atherosclerotic lesions are prone to develop, uniform laminar flow (L-flow) 1 is disturbed by recirculation, and endothelial cells are exposed to a reduced and oscillating flow (Oflow, Refs. [2] [3] [4] [5] . Therefore, it is believed that O-flow induces a pro-atherogenic response in the endothelium, whereas L-flow provokes anti-atherogenic gene expression. Indeed, VCAM-1, which plays a dominant role in the initiation of atherosclerosis (6) , is highly expressed in bifurcations of the aorta in vivo (7) and its expression is induced by O-flow in vitro (8) . In contrast, exposure to steady L-flow results in the induction of antiproliferative and anti-inflammatory gene expression (9 -12) . Quite recently, it was reported that genes under the regulatory influence of the antioxidant responsive element (ARE) are upregulated by steady L-flow (13, 14) .
The ARE is a cis-acting DNA regulatory element that coordinates the inducible expression of genes that contribute to the pivotal cellular defense mechanisms against the toxicity of electrophiles and reactive oxygen species (ROS). The ARE regulates the genes encoding a subset of drug metabolizing enzymes, such as glutathione S-transferases (GST) and NAD(P)H-quinone oxidoreductase 1 (NQO1), and a subset of antioxidant enzymes, such as heme oxygenase-1 (HO-1) and the subunits of ␥-glutamylcysteine synthetase (␥-GCS, Ref. 15) . By first heterodimerizing with a small Maf protein, the transcription factor Nrf2 (NF-E2-related factor 2) binds to the ARE to regulate the inducible expression of ARE-regulated genes (16 -18) . Under homeostatic conditions, Keap1 (Kelch-like ECH-associated protein 1) binds to Nrf2 and facilitates the degradation of Nrf2 via the proteasome system (19) . Upon exposure to electrophilic or oxidative stresses, Nrf2 is liberated from Keap1-dependent repression and accumulates in the nucleus (reviewed in Refs. 20 -25) .
In addition to its roles in the detoxification and antioxidant response, Nrf2 has been shown to play a part in the regulation of inflammation. For instance, we have demonstrated that several ARE-regulated genes are induced in an Nrf2-dependent manner in macrophages during carrageenan-induced inflammation (26) . This induction was mediated by the cyclooxygenase-2 (COX-2)-dependent generation of 15-deoxy-⌬ 12,14 -prostaglandin J 2 (15d-PGJ 2 ). In endothelial cells, the overexpression of Nrf2 or NQO1 inhibits the TNF␣-mediated activation of the VCAM-1 promoter (13) . Consistent with these anti-inflammatory functions of Nrf2, the phenotype displayed by nrf2 gene knock-out mice is pro-inflammation in various organs (reviewed in Ref. 27 ). HO-1 is known to exert a protective function against the formation of atherosclerotic lesions in vivo (28 -30) .
In this study, we elucidated the molecular mechanisms underlying activation of the ARE-Nrf2 gene battery in response to blood flow by examining Nrf2 activity in human aortic endothelial cells (HAECs). We found that exposure of HAECs to steady L-flow, but not to O-flow, induced the expression of a subset of cytoprotective genes such as NQO1 and HO-1. The essential contribution of Nrf2 to the inducible expression of these genes was confirmed by an siRNA experiment. The L-flowdependent induction of Nrf2 activity was repressed by two COX-2 inhibitors, whereas 15d-PGJ 2 was found to activate Nrf2 and induce the expression of Nrf2 target genes in HAECs. Whereas both L-flow and O-flow induced the nuclear accumulation of Nrf2 to comparable levels in HAECs, a chromatin immunoprecipitation (ChIP) assay revealed that L-flow, but not O-flow, specifically enhanced Nrf2 binding to the ARE of the NQO1 gene. These results thus demonstrate that the COX-2-dependent generation of 15d-PGJ 2 is essential for the inducible expression of Nrf2 target genes in endothelial cells in response to L-flow.
EXPERIMENTAL PROCEDURES
Cell Culture-HAECs were purchased from CAMBREX and cultured in supplemented EGM-2 medium (CAMBREX Co.) at 37°C in 5% CO 2 . Cells were used at passage 5 for flow experiments and at passages 5-7 for other experiments.
Shear Stress Apparatus-The flow system was obtained from FLEX-CELL International Corporation. A Streamer TM (STR-4000) was used to generate L-flow. An OsciFlow TM module was additionally used to generate O-flow. For flow exposure, HAEC were first cultured on gelatin-coated Culture Slips TM (FLEXCELL, 25 ϫ 75 mm). Upon confluency, cells on six Culture Slips TM were inserted into a parallel-plate flow system equipped with six chambers and exposed to the flow. StreamSoft TM software controls a flow pump, thereby regulating the flow rate into the chamber and the magnitude of fluid-induced shear stress applied to cells. Shear stress value was determined with the following formula: ϭ 6 Q/bh 2 , where is the shear stress in dyne/cm 2 , is the viscosity of the medium (0.01 dyne s/cm 2 , the same with water at 37°C), Q is the flow rate in ml/min, b is the width of the flow channel (23.4 mm), and h is the height of the flow channel (0.513 mm). For L-flow exposure, step flow (instantaneously increased from 0 to 10 dyne/cm 2 followed by steady flow during experimental period) was applied to the cells. The OsciFlow TM regulates flow direction by closing and opening pinch valves that constrict or release tubing in the valves. For O-flow, flow was regulated in oscillatory manner and shear stress value was Ϯ10 dyne/cm 2 at a frequency of 0.5 s forward/0.5 s reverse (1 Hz). The entire flow device except for OsciFlow TM module was placed in an incubator and maintained at 37°C in 5% CO 2 throughout the experiment.
Chemicals and Treatment-15d-PGJ 2 was purchased from Cayman Chemical. The solvent was evaporated under a gentle stream of nitrogen gas, and the resulting pellet was immediately dissolved in Me 2 SO before use. Nimesulide and NS-398 (Cayman Chemical) were dissolved in Me 2 SO and stored as 10-mM stock solutions until required. HAEC cultured on gelatin-coated Culture Slips TM were treated with 10 M Nimesulide or NS-398 for 2 h and subsequently exposed to flow for 6 or 24 h.
Transfection of siRNA-Nrf2 siRNA (50 and 100 M) was transfected into HAEC by Oligofectamine TM (Invitrogen) 24 h prior to flow exposure. The target sequence for human Nrf2 siRNA was 5Ј-AAG AGT ATG AGC TGG AAA AAC-3Ј. Nrf2 siRNA was purchased from Qiagen.
RNA Blot Analysis-Following flow exposure, the cells on the culture slips were scraped and collected and total RNA was extracted with ISOGEN (Wako). Two micrograms of total RNA were used for Northern blotting analysis. The RNA samples were electrophoresed and transferred onto Zeta-Probe GT membranes (Bio-Rad). Membranes were probed with 32 P-labeled cDNA probes that had been reverse-transcribed from HAECs by reverse transcriptase (RT)-PCR. Band intensities were measured by NIH imaging software and normalized with glyceraldehyde-3-phosphate dehydrogenase or ribosomal RNA.
Immunoblot Analysis-After flow exposure, the cells on the culture slips were scraped and collected, and whole cell extracts or nuclear extracts were prepared as described previously (26) . An anti-human Nrf2 antibody and anti-LaminB antibody were purchased from Santa Cruz Biotechnology. The band intensities were measured by NIH imaging software and normalized to LaminB.
Immunocytochemistry-At the end of the flow exposure, the cells on the culture slips were fixed with 10% formalin and permeabilized with 0.2% Triton-X. After blocking with 10% normal goat serum, cells were treated with rabbit polyclonal antibody raised against human Nrf2 and then treated with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (Zymed Laboratories Inc.). Cells were also stained with DAPI and observed by laser confocal microscopy (Zeiss).
ChIP Analysis-ChIP analysis was performed as previously described (31) . In brief, after flow exposure, the cells on the culture slips were fixed with formaldehyde for 10 min at room temperature. After fixation, the cells were collected by scraping and then sonicated. Immunoprecipitation analysis was carried out using control rabbit IgG and anti-Nrf2 antibody. Immunoprecipitated DNA fragments were used as templates for PCR with the following primers: human NQO1 ARE, 5Ј-AAG TGT GTT GTA TGG GCC CC-3Ј and 5Ј-TCG TCC CAA GAG AGT CCA GG-3Ј; human NQO1 second exon, 5Ј-CCT GTA GCT GAA GGT TTG CTG G-3Ј and 5Ј-CCT ACC TGT GAT GTC CTT TCT GG-3Ј. 10% of the chromatin DNA used for immunoprecipitation was similarly subjected to PCR analysis and indicated as input.
Enzyme Immunoassay-After the flow exposure, cells were cultured in fresh medium for 3 h. The prostaglandin concentration in the culture medium was measured by enzyme immunoassay using a PGD 2 -MOX EIA kit (Cayman) and a 15d-PGJ 2 Enzyme Immunoassay kit (Assay Designs, Inc.).
Plasmid Construction-Mouse Keap1 deletion mutants were generated as previously described (32) and a hemagglutinin (HA) tag was added to the N terminus. Each Cys to Ala mutant of Keap1 was produced by PCR and standard recombination techniques as previously described (33) . Constructs authenticity were confirmed by sequencing.
Immunoprecipitation Analysis-Immunoprecipitation analysis was performed as previously described (32) . Keap1 mutants were transfected into 293T cells and treated with biotin-conjugated prostaglandin (26) . Cell extracts were rendered to immunoprecipitation analysis with avidin beads and anti-HA or anti-Keap1 antibodies.
Statistics-Data were presented as means Ϯ S.D. Data were evaluated by analysis of variance and the Student's t test. p values less than 0.05 were considered statistically significant.
RESULTS

L-flow Induces the Expression of Nrf2
Target Genes-To examine whether Nrf2 is activated in response to blood flow, we exposed HAECs to either L-flow or O-flow using the Streamer (STR-4000) system equipped with an OsciFlow module (see "Experimental Procedures"). Exposure of HAECs to steady L-flow for 24 h induced the expression of the genes NQO1, HO-1, and ferritin heavy chain (FTH) (Fig. 1A) , all of which are known target genes of Nrf2. This result is in very good agreement with a previous report (13) . In contrast, exposure of HAECs to O-flow did not induce these Nrf2 target genes (Fig. 1A) . Time course studies revealed that inducible expression of the NQO1 gene occurred 12 h after exposure to L-flow (Fig. 1B) . We also found that VCAM-1 mRNA was induced 6 h after exposure to O-flow, but not to L-flow (data not shown). In contrast, exposure of HAECs to O-flow for 6, 12, and 24 h did not induce NQO1 gene expression (Fig. 1, A and B) . These results demonstrate that L-flow and O-flow regulate cytoprotective gene expression differentially in HAECs and that L-flow transduces signals that specifically activate the Nrf2-ARE pathway.
Nrf2 Is Essential for L-flow-dependent Expression of Cytoprotective Genes-We then examined whether Nrf2 actually contributes to the inducible expression of a set of ARE-regulated genes in response to L-flow. To address this issue, we knocked down the expression of endogenous Nrf2 in HAECs using the siRNA method. Transfection of Nrf2-siRNA diminished, albeit not completely, the L-flow-induced nuclear accumulation of Nrf2 ( Fig. 2A) and the gene expressions of both NQO1 and HO-1 (Fig. 2B ). These results demonstrate that Nrf2 activity is indispensable for the inducible expression of ARE-regulated genes in response to L-flow in HAECs.
We also found that the nuclear accumulation of Nrf2 in HAECs is inducible by diethylmaleate (DEM) and the proteasome inhibitor MG132, indicating that Nrf2 is regulated by electrophiles and the proteasomal protein degradation system (Fig. 2C ). This is in very good agreement with the regulation of Nrf2 activity in other cell types (23) .
COX-2 Inhibitors Attenuate Nrf2 Activation during the Acute Phase of Laminar Shear
Stress-It was recently demonstrated that 15d-PGJ 2 activates the ARE-Nrf2 pathway (26, 34) and that exposure of endothelial cells to L-flow enhances the generation of 15d-PGJ 2 through up-regulation of cytosolic phospholipase A 2 , COX-2, and L-PGD synthetase (35) (36) (37) . Therefore, we hypothesized that 15d-PGJ 2 accumulates in response to L-flow and mediates the activation of Nrf2 in endothelial cells. PGD 2 is non-enzymatically dehydrated to generate electrophilic PGs such as 15d-PGJ 2 (38) . The electrophilic nature of 15d-PGJ 2 seems to accelerate its binding to protein sulfhydryls, including the cysteines of Keap1. We therefore surmise that detecting 15d-PGJ 2 in its free form might be difficult, especially at low concentrations.
We first measured the concentration of PGD 2 in the culture medium of HAECs. Exposure of HAECs to L-flow for 6 and 24 h increased the production of PGD 2 (Fig. 3, A and B) , agreeing well with the previous report (36) . The accumulation of 15d-PGJ 2 was observed after 24 h of exposure to L-flow, but not after only 6 h (Fig. 3C) . Exposure of HAECs to O-flow for 6 h increased PGD 2 to a level comparable to that observed in the case of L-flow (Fig. 3A) , but the level did not persist until the 24-h time point (Fig. 3B) .
We next examined the effect of COX-2 inhibitors on the L-flow-induced activation of the Nrf2 pathway. Nimesulide and NS-398, two specific COX-2 inhibitors (39), had an influence on the accumulation of PGD 2 at 6-and 24-h time points (Fig. 3, A  and B) . Similarly, nimesulide and NS-398 reduced the nuclear accumulation of Nrf2 at the 6-h time point in the course of L-flow exposure. This suggests that an undetectable level of 15d-PGJ 2 or other electrophilic PGs might be generated downstream of PGD 2 and that these electrophiles might activate Nrf2 in endothelial cells (Fig. 3D) . These results indicate that the COX-2 pathway contributes to Nrf2 activation in the acute phase (i.e. 6 h) following exposure to L-flow.
On the contrary, nimesulide affected neither Nrf2 accumulation nor NQO1 and HO-1 gene expression at the 24-h time point after exposure to L-flow (Fig. 3, E and F) . Whereas we do not have a clear explanation for the lack of inhibitor effect at this time point, one plausible explanation is that an unidentified signaling pathway might compensate for the COX-2 pathway in the activation of Nrf2 in the chronic phase (i.e. 24 h) of L-flow.
Cyclopentenone PGs Activate Nrf2 by Binding to Reactive Cysteines in the Keap1 IVR-Because COX-2 inhibitor attenuated the nuclear accumulation of Nrf2 in the acute phase of L-flow, we examined if 15d-PGJ 2 , a downstream product of COX-2, activates the Nrf2 pathway in HAECs. The results demonstrated that 15d-PGJ 2 induced both Nrf2 nuclear accumulation (Fig. 4A) , and the expressions of the HO-1, NQO1, and FTH genes (Fig. 4B ) in HAECs. The nuclear accumulation of Nrf2 coincided with the induction of HO-1 gene expression and preceded induction of the NQO1 and FTH genes.
Recently, cyclopentenone PGs (cyPGs), such as 15d-PGJ 2 and ⌬ 12 -PGJ 2 , were shown to bind directly to Keap1 and activate the Nrf2-Keap1 system (26, 40) . To explore the significance of cyPGs binding to Keap1, we examined the binding of biotin-tagged 15d-PGJ 2 to Keap1 using various Keap1 deletion and point mutants (Fig. 4C) . A pull-down analysis with avidin beads followed by probing with anti-HA antibody demonstrated that HA-⌬IVR, which lacks the IVR region, binds weakly to biotin-tagged 15d-PGJ 2 compared with HA-Keap1, HA-⌬BTB, and HA-⌬DGR (Fig. 4D) . When cysteines of the IVR were mutated to alanines, Keap1 bound neither 15d-PGJ 2 nor ⌬ 12 -PGJ 2 , but this was not observed with the NTR or CTR cysteine mutants (Fig. 4E) . These results thus demonstrate that cysteines in the Keap1 IVR are essential for Keap1 to bind to 15d-PGJ 2 and ⌬ 12 -PGJ 2 and are consistent with the current hypothesis that oxidative modification of cysteines in the Keap1 IVR is important for the response to electrophiles (33, 41, 42) .
O-flow Does Not Induce Nrf2 Target Gene Expression, but Induces the Nuclear Accumulation of Nrf2-We examined whether exposure of HAECs to L-flow or O-flow increases the expression level of Nrf2 in the nucleus. Unexpectedly, we found that both L-flow and O-flow exposure induced the nuclear accumulation of Nrf2 to comparable levels as early as 6 h after exposure and that the nuclear Nrf2 level remained high during the experimental period (Fig. 5A) . To further ascertain the nuclear accumulation of Nrf2, we carried out immunocytochemical analysis of HAECs using anti-Nrf2 antibody. The result showed that Nrf2 nuclear staining was observed only weakly in the static condition, but was markedly induced by exposure to L-flow or O-flow (Fig. 5B) . In both cases, the Nrf2 signal (green) merged with DAPI nuclear staining (red) to give rise to yellow staining. These results indicate that whereas exposure of HAECs to O-flow did not induce Nrf2 target gene expression, the treatment did induce the nuclear accumulation of Nrf2.
Binding of Nrf2 to the ARE of the NQO1 Gene Is Abrogated in O-flow-treated HAECs-Using the ChIP assay, we tested whether Nrf2 accumulates in the nucleus in response to L-flow and O-flow and actually binds to the ARE in the regulatory regions of Nrf2 target genes in vivo. Exposure of HAECs to L-flow for 24 h enhanced the binding of Nrf2 to the ARE of the NQO1 gene compared with static control (Fig. 6A) . In contrast, exposure of HAECs to O-flow did not enhance Nrf2 binding to the ARE (Fig. 6A) . These results revealed that, in HAECs, the nuclear accumulation of Nrf2 is induced in response to O-flow, yet Nrf2 does not bind to the ARE under this condition (Fig. 7) .
Nrf2 requires small Maf factors as obligatory partner molecules for binding to the ARE (16) . Nrf2 may have to compete with other basic leucine zipper factors, such as Bach1-small Maf or Jun-Fos heterodimers, for binding to the ARE. Furthermore, an excess amount of small Maf factors may result in the negative regulation of ARE-dependent gene expression (43) . To test whether limiting or excess amounts of small Mafs might cause the inability of Nrf2 to bind to the ARE, we performed immunoblot analysis of small Maf protein expression. The results demonstrated that the nuclear accumulation of small Mafs was transiently induced 6 h after exposure to either O-flow or L-flow, but that the accumulation decreased by 24 h (Fig. 6B) . Neither O-flow nor L-flow caused a significant difference in the nuclear accumulation of small Mafs, excluding the possibility that a difference in small Maf protein expression contributes to the differential gene expression seen between L-flow and O-flow.
DISCUSSION
In this study, we investigated the contribution of the Nrf2-Keap1 pathway to gene expression in endothelial cells in response to fluid shear stress. Our results unveiled that exposing HAECs to steady L-flow, but not to O-flow, induces the expression of Nrf2 target genes. An unexpected observation was that both L-flow and O-flow induced the nuclear accumulation of Nrf2 to comparable levels in HAECs despite the differential gene expression in response to the flows. However, we also found that Nrf2 binding to the ARE of the NQO1 gene was significantly less in O-flow-treated cells than that in L-flowtreated cells, suggesting that in vivo binding of Nrf2 to the ARE was repressed in O-flow-treated cells. The L-flow-dependent induction of Nrf2 activity was repressed by two COX-2 inhibitors especially in the acute phase after exposure to L-flow. A COX-2 downstream molecule, 15d-PGJ 2 , was found to activate Nrf2 and induce the expression of Nrf2 target genes in HAECs through binding to IVR region of Keap1. These results support our contention that Nrf2 is the key regulator of L-flow induced anti-atherogenic gene expression and that the COX-2-dependent generation of 15d-PGJ 2 is essential for the activation of Nrf2 in endothelial cells after exposure to L-flow.
We found that pro-atherogenic O-flow induced Nrf2 nuclear accumulation to a level similar to L-flow, but that O-flow did not induce Nrf2 target gene expression. This indicates that both L-flow and O-flow generate signals in common that block Nrf2 from rapid degradation. It is interesting to note that shear stress has a profound effect on the endothelial cytoskeleton, especially on the actin and microtubule cytoskeletons (9). A, HAECs were exposed to flow and nuclear extracts were analyzed by Western blot analysis using anti-Nrf2 antibody. Densitometric analyses of the blots are shown as relative expression levels in the lower panel. #, significantly different from static control (p Ͻ 0.01). B, immunocytochemical analysis using anti-Nrf2 antibody was performed after exposure to flow for 12 h. Cells were also stained with DAPI and analyzed by confocal microscopy.
Keap1 is an actin-binding protein and the pharmacochemical disruption of the actin-cytoskelton resulted in the loss of Keap1 function (32) . Therefore, one possibility is that shear stressinduced changes in the actin-cytoskelton organization may contribute to the enfeebling of the Keap1-mediated degradation of Nrf2. Indeed, it has been reported that L-flow activates transcription factor SREBP through the F-actin-dependent Rho-ROCK-LIMK-Cofilin pathway (44) . The results also suggest that the differential responses of Nrf2 target genes to L-flow and O-flow are determined through mechanisms other than the nuclear accumulation of Nrf2.
It is well recognized that 15d-PGJ 2 exerts an anti-inflammatory function in various experimental conditions (45) . For instance, we previously demonstrated that the Nrf2 pathway was activated by the COX-2-dependent generation of 15d-PGJ 2 in macrophages. It was also reported that exposure of endothelial cells to L-flow enhanced the production of PGD 2 and 15d-PGJ 2 through up-regulation of cytosolic phospholipase A 2 , COX-2, and L-PGD synthase (35) (36) (37) . Considering these factors, we hypothesized that Nrf2 might be activated by 15d-PGJ 2 in endothelial cells and contribute to the anti-inflammatory effect of L-flow. Indeed, we found that L-flow induces the production of PGD 2 and 15d-PGJ 2 , whereas O-flow only transiently induces the accumulation of PGD 2 . These results support our contention that in the physiological condition the L-flow-specific accumulation of 15d-PGJ 2 mediates the anti-atherogenic activity of L-flow.
Treatment of endothelial cells with two COX-2 specific inhibitors weakened both the generation of PGD 2 and the nuclear accumulation of Nrf2 by L-flow at the 6-h time point. However, 24 h after exposure to L-flow, the COX-2 specific inhibitors attenuated the generation of PGD 2 , but did not enfeeble Nrf2 activation. Similarly, the inhibitors did not affect the gene expression of NQO1 or HO-1 at the 24-h time point. These results suggest that, whereas the COX-2 pathway is essential for the activation of Nrf2 in the early stage of exposure to L-flow, another yet unidentified signaling pathway acts in parallel with the COX-2 pathway in the activation of Nrf2 at the 24-h time point. In this regard, it was reported that both L-flow and O-flow increase the intracellular generation of superoxide (46) . Whereas O-flow progressively increased the generation of superoxide within 24 h, it was transiently increased by L-flow at the 1-h time point. Therefore, superoxide does not seem to be a good candidate for activating the Nrf2-Keap1 pathway in the chronic phase of L-flow exposure. Our ChIP assay revealed that L-flow enhances the binding of Nrf2 to the NQO1 ARE in vivo, whereas in contrast O-flow inducible Nrf2 did not bind to the ARE. Although the precise mechanisms creating this difference are unclear at present, competitive binding of the other transcription factors to the ARE or inhibition of Nrf2 binding to the ARE by either a protein-protein interaction or protein modification might be involved. Indeed, it was reported that PPAR␥ inhibited thromboxane synthase gene expression through a direct proteinprotein interaction with Nrf2 (47). However, although the activation of PPAR␥ by L-flow has been reported (48) , no report exists of PPAR␥ activation by O-flow, excluding the possibility that PPAR␥ acts as the determinant of Nrf2 binding to the ARE.
Overexpression of either c-Fos or Fra1 has been reported to negatively regulate ARE reporter gene expression, most probably through competitive binding to the ARE (49). Indeed, the basal level of Nrf2 target genes is increased in c-Fos knock-out mice (50) . Furthermore, switching from p45-small Maf heterodimer to Nrf2-small Maf heterodimer regulates the inducible expression of the thioredoxin gene by heme in K562 cells, whereas switching to Jun-Fos heterodimer occurs after treatment with PMA (51) . Similarly, it was reported that TGF␤ down-regulates the expression of the ␥-GCS heavy chain gene by either inducing Fra1-c-Jun heterodimer binding to the ARE (52) or inducing the expression of ATF3 (53) . In this study, we found that the expression of small Maf proteins is transiently induced by both O-flow and L-flow. Therefore, it seems of great interest to examine which set of ARE binding factors is induc- ible by differential blood flow, as this analysis would predict the competition of the transcription factor network determining Nrf2 binding capacity in vivo and finally the activation of Nrf2 target genes.
A cysteine residue at position 506 (Cys 506 ) in the DNA binding domain of Nrf2 is highly conserved among species and among the CNC family of transcription factors. Oxidation of this cysteine residue affects the DNA binding activity of Nrf2 (54) . Endothelial cells exposed to oscillatory shear stress show a marked increase in the production of ROS compared with the anti-oxidative state generated by L-flow in HUVEC (46) . Furthermore, in an ex vivo model of porcine femoral artery, reverse flow reduces the NO production via the generation of superoxide (55) . Thus, there is a possibility that the redox state differentially created by L-flow or O-flow may result in the different DNA binding activity of Nrf2 through Cys 506 . Fluid flow generates two distinct stimuli, temporal gradient of shear stress and steady shear stress (56 -58) . It is reported that temporal gradient of L-flow, but not steady L-flow, induces cell proliferation and cytokine expression (56 -58) . Both L-flow and O-flow exposure contains temporal gradient component, but steady shear component is absent in O-flow. Therefore, a signal responding to steady shear component might enhance Nrf2 binding to ARE sequences or repress a yet unknown factor which inhibits Nrf2 binding to ARE (summarized in Fig. 7) .
Atherosclerosis is one of the major causes of chronic morbidity and mortality worldwide. Although an in vitro model system has substantially expanded our understanding as to how endothelial cells respond to blood flow, knowledge is limited regarding the blood flow regulation of gene expression in vivo (5) . Future studies should shed light on the in vivo role of Nrf2 in protection against atherosclerosis.
